← Insider buys
BMRN

BioMarin Pharmaceutical Inc. · Healthcare

CEO Jean Jacques Bienaime sold $363K of BioMarin Pharmaceutical Inc.

Sold$363,120
$90.78Price
4,000Shares
−1%Stake

What BMRN did after the filing

Prices for BMRN after this filing aren't in yet.

Traded Thu, Mar 7. Filed Fri, Mar 8, 8:34 PM ET, after the close. Not investment advice.